These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9846115)

  • 1. [Specific features of cardiovascular diseases in patients with mono- and polygenic types of dyslipoproteinemia].
    Ol'binskaia LI; Zakharova VL
    Vestn Ross Akad Med Nauk; 1998; (10):56-60. PubMed ID: 9846115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks.
    Otto C; Ritter MM; Richter WO; Minkenberg R; Schwandt P
    Metabolism; 2001 Feb; 50(2):166-70. PubMed ID: 11229424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiovascular disorders, autonomic disorders and atherogenic dyslipoproteinemias in young women with the sclerotic ovary syndrome].
    Barats SS; Benediktov II; Shadrin SA
    Kardiologiia; 1984 Aug; 24(8):34-7. PubMed ID: 6492579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New prospects in the study of the relations between hypertension and atherosclerosis].
    Eliseev OM
    Ter Arkh; 1994; 66(4):71-6. PubMed ID: 8016737
    [No Abstract]   [Full Text] [Related]  

  • 5. [Genetic aspects of primary atherogenic dyslipoproteinemia].
    Turpin G; Bruckert E
    C R Seances Soc Biol Fil; 1995; 189(5):905-17. PubMed ID: 8673636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of dyslipoproteinemia on long-term results of surgical treatment of patients with obliterating atherosclerosis of the lower extremity vessels].
    Sedov VM; Mirchuk KK; Lebedev LV
    Vestn Khir Im I I Grek; 2004; 163(2):50-5. PubMed ID: 15199771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein apheresis--more than just cholesterol reduction?
    Neumann CL; Schulz EG; Hagenah GC; Platzer U; Wieland E; Schettler V
    Atheroscler Suppl; 2013 Jan; 14(1):29-32. PubMed ID: 23357137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genes, dyslipoproteinemias and atherosclerosis: from the experimental to the therapeutic].
    Fruchart JC; Duriez P
    Ann Endocrinol (Paris); 1999 Sep; 60(3):175-6. PubMed ID: 10520406
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pathophysiologic aspects of hyperlipoproteinemias].
    Soska V
    Vnitr Lek; 2000 Sep; 46(9):506-9. PubMed ID: 11344641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyslipoproteinemia in the elderly: to treat or not to treat?
    Hazzard WR
    Am J Med; 1999 Aug; 107(2A):51S-53S. PubMed ID: 10484244
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic lipoprotein disorders and coronary atherosclerosis.
    Alawadhi M; Thanassoulis G; Marcil M; Genest J
    Curr Atheroscler Rep; 2005 May; 7(3):196-203. PubMed ID: 15811253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyslipoproteinemias in diabetes.
    Steiner G
    Clin Invest Med; 1995 Aug; 18(4):282-7. PubMed ID: 8549014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Apoproteins in dyslipoproteinemia (author's transl)].
    Dewailly P
    Diabete Metab; 1981 Mar; 7(1):51-61. PubMed ID: 6786929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyslipoproteinemia and diabetes.
    Orchard TJ
    Endocrinol Metab Clin North Am; 1990 Jun; 19(2):361-80. PubMed ID: 2192878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of dyslipoproteinemia in the genesis of chronic hepatitis].
    Klimenko ED; Pozdniakov OM
    Biull Eksp Biol Med; 1992 Oct; 114(10):437-9. PubMed ID: 1288717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dyslipoproteinemias and coronary disease. Genetic markers].
    Sarriá Chueca A; Moreno Aznar L; Bueno Lozano G; Bueno Sánchez M
    An Esp Pediatr; 1989 Jun; 30(6):425-8. PubMed ID: 2572193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein Lp(a): impact on atherosclerosis and immunochemical quantification.
    Kostner GM
    Przegl Lek; 1989; 46(7):560-2. PubMed ID: 2531445
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blood lipid characteristics and the incidence of dyslipoproteinemia in the unorganized rural population of Moldova].
    Kishlaru LL
    Lik Sprava; 1995; (3-4):58-61. PubMed ID: 8819923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dyslipoproteinemia in women. Special considerations.
    Miller VT
    Endocrinol Metab Clin North Am; 1990 Jun; 19(2):381-98. PubMed ID: 2192879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 5: Normolipidemic (latent) dyslipoproteinemia.
    Choluj B
    Acta Univ Carol Med (Praha); 1991; 37(3-4):141-55. PubMed ID: 1845468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.